Your transplant team watches your new heart closely and consistently — most intensively in the first year, gradually spacing out as your risk of rejection settles and your team gains confidence in how your body is responding. Knowing what's actually being checked, and why, tends to make the schedule feel less abstract. (See Life After Transplant for the overview, and Complications After Transplant for how findings from this monitoring are actually treated.)
Endomyocardial Biopsy
The gold-standard test for detecting rejection: a small catheter is threaded through a vein (usually in the neck) into the right side of your heart, and a tiny instrument at its tip retrieves a few small tissue samples directly from your heart muscle for examination under a microscope. Access: typically your neck (the internal jugular vein), less commonly your groin. Anesthesia: local numbing medication at the access site plus light sedation for comfort — you're not put fully under general anesthesia for a routine surveillance biopsy. What to expect: it's usually a brief outpatient visit, often well under an hour of actual procedure time, and most recipients describe it as more tedious than painful once the access site is numbed. Frequency: most intensive in the first year after transplant (commonly weekly-to-biweekly at first, then progressively spaced out), tapering as your rejection risk settles — your own specific schedule is individualized by your transplant program. (See Procedures & Devices for how this compares to other catheter-based procedures.)
Non-Invasive Blood-Based Rejection Surveillance
At some transplant centers, a blood test called HeartCare (combining the AlloMap and AlloSure tests) is used once you're far enough out from transplant to reduce how often biopsies are needed, without giving up meaningful surveillance. (See HeartCare Panel: AlloMap & AlloSure for exactly what these tests measure and how results are interpreted.)
Echocardiograms
Regular ultrasound imaging of your heart — checking pumping function, valve function, and looking for signs that might suggest rejection or another developing problem, done more frequently early on and then at routine intervals. (See Cardiac Testing & Imaging.)
Coronary Angiography or Intravascular Ultrasound
Used periodically, not as frequently as biopsies, specifically to look for cardiac allograft vasculopathy (CAV) — the chronic, diffuse narrowing of the transplanted heart's blood vessels that standard angiography can sometimes underestimate, which is why intravascular ultrasound (a specialized catheter that images from inside the vessel wall) is sometimes used for a more detailed look. (See Complications After Transplant for more on CAV itself.)
Routine Blood Work
- Immunosuppression drug levels — tacrolimus and cyclosporine both have a narrow therapeutic window, so regular blood levels confirm you're in the target range: high enough to prevent rejection, not so high that toxicity risk climbs unnecessarily
- Kidney function and electrolytes — checked regularly since calcineurin inhibitors can affect kidney function over time, and several immunosuppressants affect potassium and magnesium
- Complete blood count — watches for the bone marrow suppression that some anti-rejection and prophylactic medications can cause
- CMV PCR — during and after your antiviral prophylaxis period (see CMV Disease & Monitoring After Transplant)
- Lipid panel — cardiac allograft vasculopathy risk management includes cholesterol control, part of why statins are essentially universal in transplant regimens (see Statins)
How These Fit Into a Typical Follow-Up Visit
A routine post-transplant visit generally combines a symptom check-in, vital signs, bloodwork drawn that day or shortly before, and, depending on where you are in your timeline, a scheduled biopsy or echocardiogram. Your transplant coordinator is your best resource for understanding exactly what's on your schedule at any given point and why.
Symptoms That Need Prompt Attention
Unusual fatigue, shortness of breath, new swelling, fever, or simply "not feeling right" deserve a call to your team rather than waiting for your next scheduled visit — rejection often has subtle or no symptoms early on, which is exactly why the scheduled testing above matters even when you feel completely well.
Common Questions
Do I need biopsies forever?
Not necessarily at the same frequency — many programs reduce biopsy frequency over time, sometimes substituting blood-based surveillance for some patients further out from transplant; ask your team about your own long-term monitoring plan.
What if my biopsy shows rejection but I feel completely fine?
This happens, and it's exactly why scheduled surveillance biopsies exist — early rejection is frequently silent, and catching it on a routine biopsy before symptoms develop generally leads to a better outcome than waiting for symptoms to appear.
How is a biopsy different from a regular heart catheterization?
It uses similar catheter-based access, but instead of imaging your arteries, a small instrument retrieves actual tissue samples from inside your heart muscle for direct examination.
Why do I still need blood tests if my biopsies have all been normal?
Because different tests watch for different things — biopsies detect cellular rejection directly, while blood work tracks medication levels, organ function, and infection risk, all of which matter independent of your rejection status.